Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults

Susan J. Zieman, Aruna Kamineni, Joachim H. Ix, Joshua Barzilay, Luc Djoussé, Jorge Kizer, Mary L. Biggs, Ian H. de Boer, Michel Chonchol, John S. Gottdiener, Elizabeth Selvin, Anne B. Newman, Lewis H. Kuller, David S. Siscovick, Kenneth J. Mukamal

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective: Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA1c, an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes. Research Design & Methods: Baseline HbA1c was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged ≥65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA1c and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures. Results: HbA1c was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p<0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA1c was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, end-arterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM. Conclusions: In this sample of older adults without diabetes, HbA1c was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.

Original languageEnglish (US)
Article numbere47941
JournalPLoS One
Volume7
Issue number10
DOIs
StatePublished - Oct 30 2012
Externally publishedYes

Fingerprint

glycohemoglobin
Vascular Stiffness
Fasting
Medical problems
Hemoglobins
fasting
Stiffness
Blood Pressure
Glucose
diabetes
glucose
Linear Models
Ultrasonography
Echocardiography
Ankle Brachial Index
Carotid Intima-Media Thickness
Blood pressure
Pressure measurement
Linear regression
Ankle

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Zieman, S. J., Kamineni, A., Ix, J. H., Barzilay, J., Djoussé, L., Kizer, J., ... Mukamal, K. J. (2012). Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults. PLoS One, 7(10), [e47941]. https://doi.org/10.1371/journal.pone.0047941

Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults. / Zieman, Susan J.; Kamineni, Aruna; Ix, Joachim H.; Barzilay, Joshua; Djoussé, Luc; Kizer, Jorge; Biggs, Mary L.; de Boer, Ian H.; Chonchol, Michel; Gottdiener, John S.; Selvin, Elizabeth; Newman, Anne B.; Kuller, Lewis H.; Siscovick, David S.; Mukamal, Kenneth J.

In: PLoS One, Vol. 7, No. 10, e47941, 30.10.2012.

Research output: Contribution to journalArticle

Zieman, SJ, Kamineni, A, Ix, JH, Barzilay, J, Djoussé, L, Kizer, J, Biggs, ML, de Boer, IH, Chonchol, M, Gottdiener, JS, Selvin, E, Newman, AB, Kuller, LH, Siscovick, DS & Mukamal, KJ 2012, 'Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults', PLoS One, vol. 7, no. 10, e47941. https://doi.org/10.1371/journal.pone.0047941
Zieman SJ, Kamineni A, Ix JH, Barzilay J, Djoussé L, Kizer J et al. Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults. PLoS One. 2012 Oct 30;7(10). e47941. https://doi.org/10.1371/journal.pone.0047941
Zieman, Susan J. ; Kamineni, Aruna ; Ix, Joachim H. ; Barzilay, Joshua ; Djoussé, Luc ; Kizer, Jorge ; Biggs, Mary L. ; de Boer, Ian H. ; Chonchol, Michel ; Gottdiener, John S. ; Selvin, Elizabeth ; Newman, Anne B. ; Kuller, Lewis H. ; Siscovick, David S. ; Mukamal, Kenneth J. / Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults. In: PLoS One. 2012 ; Vol. 7, No. 10.
@article{d57c96972f9446e8b918114899659967,
title = "Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults",
abstract = "Objective: Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA1c, an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes. Research Design & Methods: Baseline HbA1c was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged ≥65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA1c and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures. Results: HbA1c was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p<0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA1c was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, end-arterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM. Conclusions: In this sample of older adults without diabetes, HbA1c was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.",
author = "Zieman, {Susan J.} and Aruna Kamineni and Ix, {Joachim H.} and Joshua Barzilay and Luc Djouss{\'e} and Jorge Kizer and Biggs, {Mary L.} and {de Boer}, {Ian H.} and Michel Chonchol and Gottdiener, {John S.} and Elizabeth Selvin and Newman, {Anne B.} and Kuller, {Lewis H.} and Siscovick, {David S.} and Mukamal, {Kenneth J.}",
year = "2012",
month = "10",
day = "30",
doi = "10.1371/journal.pone.0047941",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Hemoglobin A1c and Arterial and Ventricular Stiffness in Older Adults

AU - Zieman, Susan J.

AU - Kamineni, Aruna

AU - Ix, Joachim H.

AU - Barzilay, Joshua

AU - Djoussé, Luc

AU - Kizer, Jorge

AU - Biggs, Mary L.

AU - de Boer, Ian H.

AU - Chonchol, Michel

AU - Gottdiener, John S.

AU - Selvin, Elizabeth

AU - Newman, Anne B.

AU - Kuller, Lewis H.

AU - Siscovick, David S.

AU - Mukamal, Kenneth J.

PY - 2012/10/30

Y1 - 2012/10/30

N2 - Objective: Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA1c, an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes. Research Design & Methods: Baseline HbA1c was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged ≥65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA1c and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures. Results: HbA1c was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p<0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA1c was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, end-arterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM. Conclusions: In this sample of older adults without diabetes, HbA1c was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.

AB - Objective: Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA1c, an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes. Research Design & Methods: Baseline HbA1c was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged ≥65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA1c and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures. Results: HbA1c was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p<0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA1c was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, end-arterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM. Conclusions: In this sample of older adults without diabetes, HbA1c was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.

UR - http://www.scopus.com/inward/record.url?scp=84868138299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868138299&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0047941

DO - 10.1371/journal.pone.0047941

M3 - Article

C2 - 23118911

AN - SCOPUS:84868138299

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e47941

ER -